NT-proBNP and the identification and treatment of structural heart disease and heart failure in high-risk individuals

NT-proBNP 以及高危人群结构性心脏病和心力衰竭的识别和治疗

• 批准号: nhmrc : 559010
• 负责人: A/Pr David Prior
• 金额: $ 100.45万
• 依托单位: St. Vincent's Institute of Medical Research
• 依托单位国家: 澳大利亚
• 项目类别: NHMRC Project Grants
• 财政年份: 2009
• 资助国家: 澳大利亚
• 起止时间: 2009-01-01 至 2013-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/nt-probnp-identification-risk-individuals/99238
• 关键词: NT; proBNP; identification; treatment; structural

Chronic heart failure (CHF) affects at least 300,000 Australians. It is a major burden on the community because of the costs of care, and the poor quality of life and premature death of affected individuals. This project will address the urgent need for better strategies to identify individuals with undiagnosed CHF and structural heart disease, and those who are destined to develop these conditions, who have so much to gain from currently available therapies for treatment and prevention.

慢性心力衰竭(CHF)影响着至少30万澳大利亚人。这是社区的主要负担，因为护理费用，以及受影响个人的生活质量较差和过早死亡。该项目将解决迫切需要更好的战略，以确定患有未诊断的CHF和结构性心脏病的个人，以及那些注定要发展这些疾病的人，他们将从目前可用的治疗和预防方法中获益良多。